Literature DB >> 33978298

Resveratrol improved hippocampal neurogenesis following lead exposure in rats through activation of SIRT1 signaling.

Ruike Wang1, Zuntao Wu1, Lin Bai1, Rundong Liu1, Yue Ba1, Huizhen Zhang1, Xuemin Cheng1, Guoyu Zhou1, Hui Huang1.   

Abstract

Lead (Pb) poses a potential environmental risk factor for cognitive dysfunction during early life and childhood. Resveratrol is considered a promising antioxidant with respect to the prevention of cognitive deficits and act as a potent SIRT1 agonist. Herein, this study aims to investigate the profile of neurogenesis markers following Pb exposure and to determine the regulatory role of resveratrol in this process. We confirmed firstly the protective effects of resveratrol against Pb-induced impairments of hippocampal neurogenesis in Male SD rats. Pb exposure early in life caused the altered expression of Ki-67, NeuN, caspase-3 and SIRT1 signaling, thereby resulting in spatial cognitive impairment of adolescent rats. As expected, resveratrol reduced cognitive damage and promoted neurogenesis in Pb-induced injury by regulation of SIRT1 pathway. Collectively, our study establishes the efficacy of resveratrol as a neuroprotective agent and provides a strong rationale for further studies on SIRT1-mediated mechanisms of neuroprotective functions.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  SIRT1; lead; learning and memory; neurogenesis; resveratrol

Mesh:

Substances:

Year:  2021        PMID: 33978298     DOI: 10.1002/tox.23162

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  4 in total

Review 1.  Neurogenesis in aging and age-related neurodegenerative diseases.

Authors:  Luka Culig; Xixia Chu; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2022-04-29       Impact factor: 11.788

Review 2.  Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1.

Authors:  Ruike Wang; Yingying Wu; Rundong Liu; Mengchen Liu; Qiong Li; Yue Ba; Hui Huang
Journal:  J Mol Med (Berl)       Date:  2022-03-11       Impact factor: 4.599

Review 3.  Citicoline and COVID-19: vis-à-vis conjectured.

Authors:  Hayder M Al-Kuraishy; Ali K Al-Buhadily; Ali I Al-Gareeb; Mohammed Alorabi; Nasser A Hadi Al-Harcan; Maisra M El-Bouseary; Gaber El-Saber Batiha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-09-05       Impact factor: 3.195

Review 4.  Sirtuins Modulation: A Promising Strategy for HIV-Associated Neurocognitive Impairments.

Authors:  Izchel Figarola-Centurión; Martha Escoto-Delgadillo; Gracia Viviana González-Enríquez; Juan Ernesto Gutiérrez-Sevilla; Eduardo Vázquez-Valls; Blanca Miriam Torres-Mendoza
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.